Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology.


Journal

Journal of the National Comprehensive Cancer Network : JNCCN
ISSN: 1540-1413
Titre abrégé: J Natl Compr Canc Netw
Pays: United States
ID NLM: 101162515

Informations de publication

Date de publication:
Jul 2024
Historique:
medline: 18 7 2024
pubmed: 18 7 2024
entrez: 17 7 2024
Statut: ppublish

Résumé

Breast cancer is treated with a multidisciplinary approach involving surgical oncology, radiation oncology, and medical oncology. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Breast Cancer include recommendations for clinical management of patients with carcinoma in situ, invasive breast cancer, Paget's disease, Phyllodes tumor, inflammatory breast cancer, and management of breast cancer during pregnancy. The content featured in this issue focuses on the recommendations for overall management of systemic therapy (preoperative and adjuvant) options for nonmetastatic breast cancer. For the full version of the NCCN Guidelines for Breast Cancer, visit NCCN.org.

Identifiants

pubmed: 39019058
doi: 10.6004/jnccn.2024.0035
doi:

Types de publication

Journal Article Practice Guideline

Langues

eng

Sous-ensembles de citation

IM

Pagination

331-357

Auteurs

William J Gradishar (WJ)

1Robert H . Lurie Comprehensive Cancer Center of Northwestern University.

Meena S Moran (MS)

2Yale Cancer Center/Smilow Cancer Hospital.

Jame Abraham (J)

3Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.

Vandana Abramson (V)

4Vanderbilt-Ingram Cancer Center.

Rebecca Aft (R)

5Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine.

Doreen Agnese (D)

6The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute.

Kimberly H Allison (KH)

7Stanford Cancer Institute.

Bethany Anderson (B)

8University of Wisconsin Carbone Cancer Center.

Janet Bailey (J)

9University of Michigan Rogel Cancer Center.

Harold J Burstein (HJ)

10Dana-Farber/Brigham and Women's Cancer Center.

Nan Chen (N)

11The UChicago Medicine Comprehensive Cancer Center.

Helen Chew (H)

12UC Davis Comprehensive Cancer Center.

Chau Dang (C)

13Memorial Sloan Kettering Cancer Center.

Anthony D Elias (AD)

14University of Colorado Cancer Center.

Sharon H Giordano (SH)

15The University of Texas MD Anderson Cancer Center.

Matthew P Goetz (MP)

16Mayo Clinic Comprehensive Cancer Center.

Rachel C Jankowitz (RC)

17Abramson Cancer Center at the University of Pennsylvania.

Sara H Javid (SH)

18Fred Hutchinson Cancer Center.

Jairam Krishnamurthy (J)

19Fred & Pamela Buffett Cancer Center.

A Marilyn Leitch (AM)

20UT Southwestern Simmons Comprehensive Cancer Center.

Janice Lyons (J)

3Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.

Susie McCloskey (S)

21UCLA Jonsson Comprehensive Cancer Center.

Melissa McShane (M)

22Fox Chase Cancer Center.

Joanne Mortimer (J)

23City of Hope National Medical Center.

Sameer A Patel (SA)

22Fox Chase Cancer Center.

Laura H Rosenberger (LH)

24Duke Cancer Institute.

Hope S Rugo (HS)

25UCSF Helen Diller Family Comprehensive Cancer Center.

Cesar Santa-Maria (C)

26The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.

Bryan P Schneider (BP)

27Indiana University Melvin and Bren Simon Comprehensive Cancer Center.

Mary Lou Smith (ML)

28Research Advocacy Network.

Hatem Soliman (H)

29Moffitt Cancer Center.

Erica M Stringer-Reasor (EM)

30O'Neal Comprehensive Cancer Center at UAB.

Melinda L Telli (ML)

7Stanford Cancer Institute.

Mei Wei (M)

31Huntsman Cancer Institute at the University of Utah.

Kari B Wisinski (KB)

8University of Wisconsin Carbone Cancer Center.

Kay T Yeung (KT)

32UC San Diego Moores Cancer Center.

Jessica S Young (JS)

33Roswell Park Comprehensive Cancer Center.

Ryan Schonfeld (R)

34National Comprehensive Cancer Network.

Rashmi Kumar (R)

34National Comprehensive Cancer Network.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH